SANA BIOTECHNOLOGY
Sana Biotechnology focuses on creating and delivering engineered cells as medicine for patients. Recent scientific advances make it possible to reprogram cells in the body or replace damaged cells and tissues, creating a new class of medicines to treat a broad array of diseases. The company is a team of scientists, clinicians and biotechnology veterans focused on creating an enduring company that makes meaningful medicines and will change the approach in treating diseases.
SANA BIOTECHNOLOGY
Industry:
Biotechnology Health Care Life Science Product Research
Founded:
2018-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.sana.com
Total Employee:
101+
Status:
Active
Total Funding:
700 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Domain Not Resolving Sitelinks Search Box
Current Advisors List
Board_member
2020-12-01
Current Employees Featured
Christian Hordo Chief Business Officer @ Sana Biotechnology
Chief Business Officer
Richard C. Mulligan Head of SanaX @ Sana Biotechnology
Head of SanaX
Edward Rebar SVP and Chief Technical Officer @ Sana Biotechnology
SVP and Chief Technical Officer
2020-03-01
Aaron Foster Vice President - Immunology @ Sana Biotechnology
Vice President - Immunology
2020-12-01
Farah Anwar Head of R&D Operations and IDE Leader @ Sana Biotechnology
Head of R&D Operations and IDE Leader
Shanna Peek SVP, Corporate Operations @ Sana Biotechnology
SVP, Corporate Operations
Nate Hardy Chief Financial Officer @ Sana Biotechnology
Chief Financial Officer
2019-01-01
Chad Cowan Chief Scientific Officer @ Sana Biotechnology
Chief Scientific Officer
2019-01-01
Paul Brunetta Head of Clinical & Translational Science @ Sana Biotechnology
Head of Clinical & Translational Science
Terry Fry Head of T Cell Therapeutics @ Sana Biotechnology
Head of T Cell Therapeutics
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-10-30 | Oscine Therapeutics | Oscine Therapeutics acquired by Sana Biotechnology | N/A |
Investors List
Bezos Expeditions
Bezos Expeditions investment in Series A - Sana Biotechnology
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board investment in Series A - Sana Biotechnology
ARCH Venture Partners
ARCH Venture Partners investment in Series A - Sana Biotechnology
F-Prime Capital
F-Prime Capital investment in Series A - Sana Biotechnology
GV
GV investment in Series A - Sana Biotechnology
Alaska Permanent Fund
Alaska Permanent Fund investment in Series A - Sana Biotechnology
Altitude Life Science Ventures
Altitude Life Science Ventures investment in Series A - Sana Biotechnology
Omega Funds
Omega Funds investment in Series A - Sana Biotechnology
Flagship Pioneering
Flagship Pioneering investment in Series A - Sana Biotechnology
Baillie Gifford
Baillie Gifford investment in Series A - Sana Biotechnology
Official Site Inspections
http://www.sana.com Semrush global rank: 1.18 M Semrush visits lastest month: 26.4 K
Unable to get host informations!!!
